School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK.
School of Natural and Environmental Sciences, Ridley Building 2, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK.
Microbiology (Reading). 2019 Dec;165(12):1252-1264. doi: 10.1099/mic.0.000822.
The rationale of our bioprospecting campaigns is that the extremobiosphere, particularly the deep sea and hyper-arid deserts, harbours undiscovered biodiversity that is likely to express novel chemistry and biocatalysts thereby providing opportunities for therapeutic drug and industrial process development. We have focused on actinobacteria because of their frequent role as keystone species in soil ecosystems and their unrivalled track record as a source of bioactive compounds. Population numbers and diversity of actinobacteria in the extremobiosphere are traditionally considered to be low, although they often comprise the dominant bacterial biota. Recent metagenomic evaluation of 'the uncultured microbial majority' has now revealed enormous taxonomic diversity among 'dark' and 'rare' actinobacteria in samples as diverse as sediments from the depths of the Mariana Trench and soils from the heights of the Central Andes. The application of innovative culture and screening options that emphasize rigorous dereplication at each stage of the analysis, and strain prioritization to identify 'gifted' organisms, have been deployed to detect and characterize bioactive hit compounds and sought-after catalysts from this hitherto untapped resource. The rewards include first-in-a-class chemical entities with novel modes of action, as well as a growing microbial seed bank that represents a potentially enormous source of biotechnological and therapeutic innovation.
我们的生物勘探活动的基本原理是,极端生物圈,特别是深海和超干旱沙漠,蕴藏着尚未被发现的生物多样性,这些生物多样性可能表达出新颖的化学物质和生物催化剂,从而为治疗药物和工业过程的开发提供机会。我们专注于放线菌,因为它们在土壤生态系统中经常扮演着关键物种的角色,并且在生物活性化合物的来源方面有着无与伦比的记录。尽管放线菌通常构成了主要的细菌生物群,但在极端环境中,放线菌的种群数量和多样性传统上被认为较低。最近对“未培养的微生物多数”的宏基因组评估表明,在马里亚纳海沟深处的沉积物和安第斯山脉高处的土壤等各种样本中,“黑暗”和“稀有”放线菌之间存在巨大的分类多样性。应用创新的培养和筛选方法,强调在分析的每个阶段进行严格的去重复,以及对菌株进行优先级排序以识别“有天赋”的生物,已经被用来从这个迄今为止尚未开发的资源中检测和表征具有生物活性的化合物和所需的催化剂。回报包括具有新颖作用模式的一流化学实体,以及一个不断增长的微生物种子库,这代表了生物技术和治疗创新的潜在巨大来源。